Objectives: To evaluate the impact of morphological features of inferior vena cava thrombus on the overall survival and cancer-specific survival (cancer-specific survival of patients with renal cell carcinoma). Methods: We retrospectively analyzed the records of 156 renal cell carcinoma patients with inferior vena cava thrombus who underwent radical nephrectomy and thrombectomy from 1998 to 2013 at five tertiary centers. Inferior vena cava thrombi were classified as spherical (type I) and spiculated (type II) according to morphological features on computed tomography or magnetic resonance imaging. Multivariate cox regression models were used to quantify the impact of prognostic factors on overall survival and cancer-specific survival. Results: Type I was found in 29 patients (18.6%), and type II in 127 patients (81.4%). Median follow up was 38.2 months (interquartile range 12-57). Demographic characteristics were not significantly different, except for the cranial thrombus height (P = 0.003). On multivariate analysis, Eastern Cooperative Oncology Group performance score, clinical tumor size, distant metastasis, histologic subtype, thrombus morphology and remnant venous thrombus significantly affected overall survival in pN any M any patients (all P < 0.05). Among the pN O / X M O patients, clinical tumor size, histologic subtype, thrombus morphology and remnant venous thrombus significantly affected overall survival (all P < 0.05). In terms of cancer-specific survival, Eastern Cooperative Oncology Group performance score, clinical tumor size, distant metastasis, histologic subtype and thrombus morphology significantly affected cancer-specific survival in pN any M any patients (all P < 0.05). In patients with pN O / X M O , body mass index, clinical tumor size, histological subtype, thrombus morphology and remnant venous thrombus significantly affected cancer-specific survival (all P < 0.05). Conclusion: Clinical tumor size, histological subtype, and thrombus morphology are independent predictors of overall survival and cancer-specific survival in renal cell carcinoma patients with inferior vena cava thrombus. These factors might be helpful for the surgeon's determination to improve therapeutic efficacy.
Introduction
There is a 4-36% prevalence of venous thrombus at time of diagnosis of RCC. 1 Subclinical metastases are present in approximately 60% of these patients; progression in such patients is rapid, as evidenced by a 1-year disease-specific survival of 29% among untreated patients. 2, 3 Aggressive resection remains the only curative therapeutic modality in these patients, but is still a challenging procedure for urologists, with a high perioperative mortality rate of 2-10%. [4] [5] [6] Studies to date have shown that the prognostic factors for RCC with venous thrombi include the laboratory serum values, tumor thrombus level, histological type, Fuhrman grade, lymph node involvement and the presence of distant metastases; however, most of these studies include sizeable numbers of patients with thrombi not extending beyond the renal vein, limiting the assessment of the effect of thrombi involving the IVC on survival. 7, 8 Furthermore, although several previous studies have dealt with the properties of the thrombus itself, such as tumor thrombus consistency and bland thrombus, as prognostic factors, they used intraoperative or pathological findings to assess prognostic value and were thus of limited use in predicting preoperative prognostic evaluation. [9] [10] [11] In the present study, the thrombus morphology, as determined using preoperative imaging studies (CT or MRI), was examined in RCC patients with IVC thrombi who had undergone surgical treatment to assess its feasibility as a prognostic factor.
Methods Patients
After institutional review board approval, medical records were reviewed to identify RCC patients who had IVC thrombus. Among the 198 consecutive patients, we retrospectively analyzed 156 RCC patients with IVC thrombus who underwent radical nephrectomy with IVC thrombectomy between December 1998 and December 2013. Data were collected from five tertiary centers in Korea, and cases lacking vital information or images of sufficient quality were excluded. Clinical and pathological variables were comprehensively reviewed for each patient identified. Histological subtype was determined according to the 1997 World Health Organization Heidelberg classification. Excluded criteria consisted of incomplete records, renal vein thrombus and neoadjuvant target therapy. Tumor nuclear grade was classified according to the Fuhrman system. Pathological staging was determined according to the 2009 TNM staging system of the American Joint Committee on Cancer. The Mayo classification was used for determining the macroscopic extent of the IVC thrombus. Thrombi within the IVC, and <2 cm from the confluence of the renal vein and the IVC were classified as level I. Thrombi extending within the IVC to over 2 cm above the confluence of the renal vein and the IVC, but still below the level of the hepatic vein, were classified as level II. Thrombi involving the intrahepatic IVC were classified as level III. Thrombi extending above the diaphragm or into the right atrium were classified as level IV. 12 However, previous reports have identified that tumor level alone is not sufficient to predict the survival. 13 Associations between radiographic IVC thrombus diameter and the risk of IVC wall invasion have been published in small series.
14 Therefore, the present study estimated preoperative thrombus height as well as thrombus diameter.
Imaging and morphological assessment
High-quality imaging work-up is one of the most essential aspects of the management of RCC patients with IVC thrombi. Each center might have specific preferences regarding their imaging modality of choice. Both CT and MRI examinations can provide high-quality images to delineate the extent of the thrombi. Recent studies support the notion that the choice of imaging modality is irrelevant, as both modalities have excellent sensitivity and specificity in identifying the presence and extent of IVC thrombus. The IVC thrombi were classified into two types according to the morphology of the thrombi on preoperative imaging studies. Thrombi with a round shape, smooth margin and suggestive of a pseudocapsule, as shown on Figure 1a , were classified as type I, whereas those with irregular, sharp or friable margins, as shown on Figure 1b , were classified as type II. To ensure the validity of the morphological data, a total of three observers, one radiologist (specializing in uroradiology) and two urologists, were involved in characterization of the thrombi, and the classification was carried out without prior knowledge of the clinical data of the patients; in cases of discordance between the observers, majority rule was applied in determining the type of the thrombus. Interreader variability for the imaging variables was calculated using Lin's concordance correlation coefficient. Interreader reliability measured using the interobserver correlation coefficient was 80.8% (P < 0.001) for each morphological characteristic.
Statistical analysis
The Kaplan-Meier method was used to estimate and CSS. Differences between type I and type II thrombi were assessed Table 2 , examination of deaths within 90 days of surgery showed that although there were no such deaths in the type I thrombus group, eight deaths occurred in the type II thrombus group (6.3%). In pN any M any patients, the 5-year OS was 82.6% in the type I thrombus group, and 32.5% in the type II thrombus group (log-rank 0.002; Fig. 2a ). On multivariable analysis, ECOG performance score (P = 0.006), clinical tumor size (P < 0.001), presence of distant metastasis (P = 0.011), histological subtype (P < 0.001), morphology of tumor thrombus (P = 0.001) and remnant venous thrombus (P = 0.029) were significantly associated with OS in the entire cohort group (Table 3) . Although BMI (P = 0.749), preoperative hemoglobin (P = 0.223) and tumor laterality (P = 0.082) showed Fig. 2b ). On multivariable analysis, clinical tumor size (P = 0.001), histological subtype (P < 0.001), morphology of tumor thrombus (P = 0.006) and remnant venous thrombus (P < 0.001) were associated with OS in pN O / X M O patients (Table 3) . BMI (P = 0.091) and preoperative hemoglobin (P = 0.282) did not correlate significantly with OS. Assessment of CSS, after exclusion of patients who died within 90 days after surgery and those who died due to other causes, showed that the 5-year CSS was 82.6% in the type I thrombus group and 33.9% in the type II thrombus group (log-rank 0.002; Fig. 2c ). On multivariable analysis, ECOG performance score (P = 0.001), clinical tumor size (P < 0.001), distant metastasis (P = 0.008), histological subtype (P < 0.001) and morphology of tumor thrombus (P = 0.001) were shown to affect CSS in patients with pN any M any (Table 4) . Preoperative hemoglobin (P = 0.304), BMI (P = 0.768), tumor laterality (P = 0.054) and remnant venous thrombus (P = 0.127) were not significantly correlated with CSS. In contrast, in pN O / X M O patients, the 5-year CSS was 93.8% for those in the type I thrombus group and 47.4% for those in the type II thrombus group (log-rank 0.008; Fig. 2d ). Multivariable analysis showed that BMI (P = 0.041), clinical tumor size (P = 0.003), histological subtype (P < 0.001), thrombus morphology (P = 0.003) and remnant venous thrombus (P < 0.001) were significantly associated with CSS in pN O / X M O patients (Table 4) . Although preoperative hemoglobin (P = 0.152) showed significant correlation on univariable analysis, it was not significant on multivariable analysis.
Discussion
RCC with IVC thrombus, when untreated, is associated with high mortality, with a 1-year disease-specific survival of 29% reported in such patients. 2 Appropriate surgical intervention, however, only achieves a 5-year CSS of <50%.
7,13,15 Furthermore, major complications were recorded in 34% of patients after surgery, and the mortality rate within 90 days after surgery was 10% for RCC patients who had tumor thrombus in the upper IVC. 16 As a result, the treatment of RCC with IVC thrombus remains a challenge in urological oncology.
Following recent multicenter studies involving RCC patients with IVC thrombi, greater effort is being put into identifying the prognostic factors in such patients. [7] [8] [9] Previously established prognostic factors (tumor size, local extension, nodal involvement, performance status and distal metastasis) were reappraised, 3, 17, 18 and additional factors, such as tumor thrombus consistency, bland thrombus and histological type, have been found to be of prognostic value. 7,9-11 However, many of these studies have included cases in which the prognosis could only be established postoperatively and the many cases of renal vein thrombus were included. Thus, in the present study, only cases of RCC with IVC thrombus were examined to identify prognostic factors, and, unlike in previous studies, the morphology of thrombus on preoperative imaging studies was assessed for its prognostic value.
In the present study, the IVC thrombi were classified into two types according to the thrombus morphology in order to determine which type of thrombus was affected regarding long-term survival. Type I thrombi was applied within more stringent standards than type II thrombi; therefore, the number of patients differed in both types. Nevertheless, the number of enrolled patients is not fewer than previous studies.
On multivariable analysis involving pN any M any patients, ECOG performance score (P = 0.006), clinical tumor size (P < 0.001), presence of distant metastasis (P = 0.011), histological subtype (P < 0.001), morphology of tumor thrombus (type I vs type II; P = 0.001) and remnant venous thrombus (P = 0.029) were shown to affect OS.
In contrast, clinical tumor size (P = 0.001), histological subtype (P < 0.001), morphology of tumor thrombus (type I vs type II; P = 0.006) and remnant venous thrombus (P < 0.001) were shown to affect OS in pN O / X M O patients. Postoperative remnant venous thrombus was thought to correlate with OS not only because of inclusion of cases in which the patients died within 90 days after surgery, but also deaths as a result of venous thromboembolism (aside from deaths directly attributable to RCC); in RCC patients with IVC thrombus, the incidence of venous thromboembolism has been reported to be 5.7%. 19 As for CSS, multivariable analysis involving pN any M any patients showed that, similar to previously published studies, ECOG performance score (P = 0.001), clinical tumor size (P = 0.001), distant metastasis (P = 0.008), histological subtype (P < 0.001) and morphology of tumor thrombus (type I vs type II; P = 0.001) were significant prognostic factors. In contrast, BMI (P = 0.041), clinical tumor size (P = 0.003), histological subtype (P < 0.001), thrombus morphology (P = 0.003) and remnant venous thrombus (P < 0.001) were shown to be a significant prognostic factors in pN O / X M O patients (P = 0.031). This is the first research to determine the prognostic factor for thrombus morphology by preoperative imaging study. The type I thrombi had better prognosis compared with type II thrombi; therefore, these patients should be considered for surgical intervention more positively.
The appraisal of thrombus morphology as a prognostic factor is based on the hypothesis that thrombi will appear differently on CT or MRI images depending on their characteristics, and will correspondingly differ in their prognoses, but this concept has not been investigated in previous studies. The current study aimed to validate if thrombus consistency could serve as a prognostic factor for patients' survival. 10, 20 However, some studies argued that is no difference in survival between solid and friable thrombus consistency. 20, 21 In thrombus-forming tumors, thrombi with relatively benign courses are more likely to be homogeneous and markedly hypoattenuating, whereas those with more malignant courses tend to be adherent to vessel walls, and collateral pathways are common. 22 In addition, as shown in Figure 3a ,b, pseudo-capsulation, as observed in RCC, occurs not only on solid masses, but also tumor thrombi, and, histologically, such pseudo-capsulation and margination of thrombi occur in the presence of abundant fibrotic tissue components. 23 The difference in survival associated with thrombi morphology as observed in the present study might be considered to support the hypothesis that increased fibrotic tissue content of a thrombus would result in a more stable morphology, thus, reduced pre-or intraoperative dissemination of thrombi into remote areas.
Additionally, patients with non-clear cell RCC subtypes influenced OS and CSS compared with clear cell RCC subtype, as observed in previous studies. 7, 24, 25 In the case of clear cell RCC, the expression of E-cadherin is increased compared with non-clear cell RCC, and such increases are associated with better prognosis, whereas reduced expression of E-cadherin has been associated with poorer prognosis and higher Fuhrman grades. 26 Recent studies on the relationship between prognosis and tumor consistency have classified tumor thrombi into friable or solid according to the level of expression of E-cadherin.
9,10 Accordingly, thrombus morphology as observed on CT and MRI images might be considered to be a reflection of the histological characteristics and level of expression of cell adhesion molecules.
The effect of thrombus level on prognosis remains controversial. Some studies have reported a relationship between survival and thrombus level, 8, 27 whereas others did not identify thrombus level as a prognostic factor. 3, 12, 28 A study published by Tilki et al. has shown that level I thrombi (according to the Mayo Clinic classification) differed from level II-IV thrombi in terms of prognosis, but no such difference was observed between levels II, III and IV. 7 Additionally, in recent studies with larger cohorts, thrombus with above the diaphragm is a predictor of perioperative complication, but not predictor of CSS. 16, 29 Likewise, in the present study, thrombus level did not affect OS.
Several clinicopathological factors influenced patients' survival. In previous studies, ECOG performance score was influenced by patients' survival. 4, 30 In the present study, ECOG performance status was also influenced by OS and CSS in patients with pN any M any . As known, clinical tumor size also influenced OS and CSS. 25 Furthermore, for non-metastatic patients, remnant venous thrombus correlated significantly with a poor prognosis. In patients with remnant venous thrombus, the risk of postoperative cardiopulmonary venous thromboembolic events is increased. 30 The influence of BMI has been published in several studies. Lower BMI indicated poor nutrition status. Higher BMI was associated with better postoperative performance, at least for OS. 29, 30 In the present study, higher BMI affected lower CSS in patients with non-metastatic RCC.
The present study had several important limitations. First and foremost were the limitations inherent to retrospective analyses. Data were not collected prospectively, so our multicenter dataset was limited because of missing data. Second, the multicenter nature of the study might have led to interinstitutional differences in radiological and pathological findings. To minimize these differences, all radiological images were reviewed by three experts (a uroradiologist and two urologists). Relatively good concordance (interobserver correlation coefficient was 80.8%) was shown between the three specialists who carried out radiological evaluation of the thrombus morphology. Finally, compared with the previous study, a relatively small number of patients who underwent lymph node dissection could affect the multivariable analysis. We plan to carry out a prospective study to determine the exact outcomes.
Our multi-institutional study cohort provides to define the role of thrombus morphology in RCC with IVC thrombus. As a result, thrombus morphology was shown to affect both OS and CSS. Whether the relationship between thrombus morphology and prognosis reflects the biological aggressiveness of the tumor itself or the result of the effect of morphology on tumor manipulation is beyond the scope of the present study. Traditionally known prognostic factors, such as clinical tumor size, histological subtype, distant metastasis, ECOG performance score, BMI and remnant venous thrombus, were influencing factors for OS and/or CSS. Further investigation including prospective randomized trials and external validation at other institutions are necessary for more reliable and definitive results.
In conclusion, thrombus morphology could be introduced in a risk stratification model, and can be used in the process of planning surgical decision. 
